BioXcel Therapeutics Stock (NASDAQ: BTAI) stock price, news, charts, stock research, profile.
You can purchase shares of BioXcel Therapeutics (NASDAQ:BTAI) through any online brokerage.
There are no as such competitors for BioXcel Therapeutics.
BioXcel Therapeutics has a consensus price target of $5.61.
The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $0.3265 last updated January 30, 2025 at 7:42 PM EST.
There are no upcoming dividends for BioXcel Therapeutics.
BioXcel Therapeutics’s Q4 earnings are confirmed for Tuesday, March 11, 2025.
There is no upcoming split for BioXcel Therapeutics.
BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.